Center for AIDS Prevention Studies, Department of Medicine, University of California - San Francisco, San Francisco, CA, USA.
Center for AIDS Prevention Studies, University of California, San Francisco, 550 16th Street, 3rd Floor, San Francisco, CA, USA.
AIDS Behav. 2018 Mar;22(3):939-947. doi: 10.1007/s10461-017-1759-9.
Relying on the most frequently reported barriers to adherence and convenient definitions of non-adherence may lead to less valid results. We used a dominance analysis (a regression-based approach) to identify the most important barriers to adherence based on effect size using data collected through an online survey. The survey included the Adherence Barrier Questionnaire, self-reported non-adherence defined as a 4-day treatment interruption, and HIV clinical outcomes. The sample (N = 1217) was largely male, gay identified, and White. Nearly 1 in 3 participants reported "simply forgot" as a barrier; however, in a dominance analysis, it yielded a small effect size it its association with a 4-day treatment interruption. Further, dominance analyses stratified by race/ethnicity and age suggested that not all barriers impact all groups equally. The most frequently reported barriers to adherence were not the most important, and interventions should focus on barriers more strongly linked to clinical outcomes.
依赖于最常报告的依从性障碍和非依从性的便捷定义可能会导致结果不够有效。我们使用优势分析(基于回归的方法),根据通过在线调查收集的数据,根据效果大小确定依从性的最重要障碍。该调查包括依从性障碍问卷、自我报告的非依从性定义为 4 天的治疗中断以及艾滋病毒临床结果。样本(N=1217)主要为男性、同性恋者和白人。近三分之一的参与者报告“只是忘了”是一个障碍;然而,在优势分析中,它与 4 天的治疗中断相关,其关联的效果很小。此外,按种族/族裔和年龄分层的优势分析表明,并非所有障碍对所有群体的影响都是相同的。报告最多的依从性障碍并不是最重要的,干预措施应侧重于与临床结果更紧密相关的障碍。
J Adolesc Health. 2017-4
BMC Fam Pract. 2021-10-30
AIDS Patient Care STDS. 2018-10-19
Ann Behav Med. 2017-2